Today, with the rapid development of medical science and technology, minimally invasive intervention technology, as an innovative force in the medical field, is promoting the development of medical career at an unprecedented speed. On December 7, 2024, “The 16th China Minimally Invasive Interventional Medicine Academic Conference and Minimally Invasive Diagnosis and Treatment New Technology Learning Class (2024CMIC), the Annual meeting of the Zhongguancun Minimally Invasive Cancer Treatment Industry Technology Innovation Strategic Alliance, and the Annual meeting of the Interventional Radiology Branch of the Beijing Medical Doctor Association” were held in Beijing.
The conference attracted many well-known experts and scholars in the field of tumor therapy and minimally invasive intervention in China to explore the recent progress and development trend in the field of minimally invasive tumor therapy. This grand event not only marks a new stage of development in the field of minimally invasive cancer therapy in China, but also highlights the firm will and remarkable achievements of the medical community in exploring a new path of cancer treatment.
The conference was co-sponsored by Zhongguancun Minimally Invasive Cancer Treatment Industry Technology Innovation Strategic Alliance (hereinafter referred to as “Alliance”), Beijing Medical Doctor Association Interventional Radiology Specialist Branch, Peking University International Hospital, Beijing You ‘an Hospital Affiliated to Capital Medical University.
Peking University Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital, Peking Union Medical College Hospital and other authoritative medical institutions jointly undertook. With the core theme of “Starting a new journey of minimally invasive development and creating a new international first-class alliance”, the conference aims to accelerate China’s minimally invasive tumor cause toward internationalization through in-depth exchanges and extensive cooperation, and lead the innovation and development of global tumor micro-non-invasive diagnosis and treatment technology.
The opening ceremony kicked off in a solemn and warm atmosphere. Zheng Jiasheng, chairman of Zhongguancun Minimally invasive Cancer Treatment Industry Technology Innovation Strategic Alliance, gave a welcome speech, the National Minimally invasive Alliance and interventional physician specialist Summit has been developed for more than ten years, here, to the leaders, experts, colleagues and enterprises of the strong support, as well as alliance members, branches of the joint efforts, express heartfelt thanks.
In order to effectively promote the implementation of the minimally invasive tumor concept, the National Minimally Invasive Tumor Alliance and Peking University International Hospital jointly established the minimally invasive tumor Department, which is committed to building a minimally invasive tumor demonstration base integrating medical treatment, teaching and scientific research. Professor Zheng Jiasheng said that this innovative initiative not only created a new situation of the common development of inclusive medical care and international medical care, but also injected new vitality into the rapid development of China’s minimally invasive cancer cause.
The establishment of this platform will help the hospital to provide a new minimally invasive treatment model of tumor with three guarantees: anatomical structure, physiological function and immunity, and realize lung function-treatment of lung cancer, thyroid function treatment of thyroid tumor, breast function treatment of breast tumor, liver function treatment of liver tumor, and kidney function treatment of kidney tumor.
Provide active diagnosis and treatment mode: early screening, early diagnosis, early minimally invasive ablation for the treatment of very early lung cancer at the stage of lung grinding glass nodules and other new tumor treatment concepts; The new concept of providing minimally invasive surgery for long-term survival of patients with advanced tumors.
Provide a new minimally invasive radical treatment model for pancreatic cancer, hilar cholangiocarcinoma, portal vein cancer combined, hepatic vein cancer combined, inferior vena cava cancer combined, refractory tumor, recurrent tumor and rare tumor, and further promote the homogenization, popularization and application of minimally invasive tumor treatment technology. To bring more patients the hope of life and the Gospel of health.
“On the occasion of the 10th anniversary of the opening of Peking University International Hospital, the establishment of the Minimally invasive Oncology department conforms to the general trend of tumor treatment and the future development of medicine, and is a major breakthrough to help Peking University International move toward the goal of internationalization.” Yu Feng, vice president of Peking University International Hospital, believes that the establishment of this department has added advanced cutting-edge technology to tumor diagnosis and treatment, making complex surgery simple, difficult to treat diseases into easy to treat, or even untreatable diseases into treatable diseases, while solving the disease to the maximum extent, retaining the normal anatomical structure, physiological function and immune function, and stimulating the body’s own immune function.
Related topics
